Supervivencia Global en Segunda Línea de Liposarcomas: un objetivo alcanzado

48 / 86

Eribulin Dacarbazine
Median (months) 2.9 1.7
HR (95% CI) 0.52 (0.346–0.784)
P-value 0.0015
CI, confidence interval; HR,
hazard ratio.
Chawla SP, et al. Presented at CTOS 2015 Annual Meeting, Salt Lake City, UT, November 4-7, 2015
1.2 month improvement in median OS with eribulin
Study 309 (LPS): Liposarcoma Progression-Free Survival